Health
New study to examine the effects of MS disease-modifying therapy on cognitive fatigue – News-Medical.Net
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab…
Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).
John DeLuca, PhD, senior vice president of Research and Training, is principal investigator for the study titled, “A Biomarker for Cognitive Fatigue in MS using Functional Imaging”. The study team includes Glenn Wylie, DPhil, director…
-
General22 hours agoWondering about winter | The Spectator Australia
-
General20 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Noosa News21 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
Business23 hours agoWiseTech shares lift off amid agreement with founder Richard White